The most recent data on the evolution of COVID-19, in the last 24 hours, in Québec show:
439 new cases, bringing the total number of people infected to 1,330,427*;
5 new deaths, for a total of 18,324 deaths;
0 deaths in the last 24 hours,
1 death that occurred between two and seven days ago,
4 deaths that occurred more than seven days ago;
NOTE: As death removals are not shown in the data above, the number of death additions may exceed the number of new deaths for the day.
1,590 health care workers absent for COVID-related reasons (preventive withdrawal, isolation, awaiting results, etc.);
1,144 hospitalizations, including 391 due to COVID-19, for a decrease of 23;
227 new entries,
250 new discharges;
39 people in intensive care, including 23 due to COVID-19, for an increase of 10;
19 new entries,
9 new discharges;
6,713 samples conducted on April 3;
327,145 self-declared rapid tests so far, including 276,189 positive: 42 declared for yesterday, including 37 positive.
*Note that the number of cases listed is not representative of the situation since access to screening centres is restricted to priority clienteles.
Vaccination
2 348 doses administered are added, for a cumulative total of 23,002,403 doses received by Quebecers.
To follow the evolution of the data on a daily basis, consult the open data or the INSPQ website at https://www.donneesquebec.ca/recherche/fr/organization/msss or at https://www.inspq.qc.ca/covid-19/donnees. Note that certain data, especially the number of cases, deaths and doses administered, may be subject to daily readjustment for previous days, given that a catch-up is necessary due to a delay in data entry.
A reminder concerning public health instructions:
To limit the spread of the coronavirus as much as possible, it is important to follow basic preventive measures such as hand washing, physical distancing, wearing a face covering and following the instructions in effect.
Remember that in the event of symptoms, it is always essential to isolate yourself and consult one of the self-care guides or call 1-877-644-4545 (or the telephone code corresponding to the region concerned) to find out the measures to be taken.
Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today announced its investment in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products containing low-GWP (Global...
Lantern Pharma Inc. , a leading artificial intelligence (AI) oncology drug discovery and development company, today announced a strategic AI-driven collaboration with French biotechnology company, Oregon Therapeutics to optimize the development of...
A recent global survey conducted by the World Lupus Federation reported that 91% of survey respondents were taking or have taken oral steroids to treat their lupus. Over 7,700 people living with lupus from more than 100 countries participated in the...
Calliditas Therapeutics AB ("Calliditas") today announced data from the proof-of-concept Phase 2 trial evaluating setanaxib, its lead NOX enzyme inhibitor, in combination with pembrolizumab, in patients with squamous cell carcinoma of the head and...
The Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation announced a new partnership to support critical scientific research and development (R&D) for global health. The partnership is focused on supporting science and...